Skip to main content

Advertisement

Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016

Fig. 1

Long-term survival after autologous stem-cell transplantation (ASCT): a overall survival and non-relapse mortality, b overall survival by harvest yield in millions of CD34+ cells/kg patient (with bone-marrow harvested patients included as a separate category) and, c overall survival using the 5 million CD34+ cells/kg patient cut point

Back to article page